SUMMARY
INTRODUCTION
Exopolysaccharide (EPS) is a key component of the biofilm matrix in many biofilmforming bacteria and may be composed of various sugar polymers (1) . It has an important role in immune evasion and tolerance toward antibacterial agents. By far most known EPS molecules are neutral or polyanionic (2) . Enzymatic alteration of EPS is believed to significantly change its physico-chemical properties and thus, biofilm structure.
However, particularly in gram-positive bacteria, EPS-modifying enzymes and the relationship between the composition of EPS and its biological function have remained poorly characterized.
The Gram-positive bacterium Staphylococcus epidermidis is the most prevalent pathogen involved in hospital-acquired infections (3) . The costs related to infections caused by S. epidermidis in the hospital setting are enormous and represent a major health care burden. Most infections caused by S. epidermidis occur after the insertion of indwelling devices such as catheters or prosthetic heart valves. In these cases, the ability of S. epidermidis to form biofilms represents the most important virulence determinant (3) . In a biofilm, the bacteria are dramatically less susceptible to antibiotic treatment and attacks by innate host defense. For these reasons, S. epidermidis biofilm-associated infections are very difficult to eradicate.
PIA, a homopolymer of β-1,6-linked N-acetylglucosamine (GlcNAc) residues, is located in fibrous strands on the S. epidermidis cell surface, where it serves as an essential factor involved in biofilm formation (4) . Importantly, it protects the pathogen from innate host defense (5) . PIA production is crucial for virulence in animal infection by guest on http://www.jbc.org/ Downloaded from models (6) (7) (8) and is encoded by the ica gene locus, which consists of the icaA, icaD, icaB, and icaC genes (9) . IcaA and IcaD form a UDP-GlcNAc transferase located in the cellular membrane (10) . Another putative membrane protein, IcaC, is required for the formation of longer polymers and might be involved in the export of the growing PIA chain (10) . PIA represents a very unusual EPS molecule, as some GlcNAc residues become deacetylated, which produces a positive net charge of the polymer. The basis of deacetylation is unclear. PIA is also produced in Staphylococcus aureus and some strains of Escherichia coli (11, 12 (12) (13) (14) . In Y. pestis, for example, ica homolog-dependent biofilms are crucial for vector transmission from fleas to humans (15) . Thus, it is likely that PIA production represents an important virulence determinant in a series of infectious diseases.
Here we describe the role of the IcaB protein in PIA biosynthesis and S . epidermidis pathogenesis. We show that IcaB is located on the S. epidermidis cell surface and involved in the introduction of positive charges in the PIA polymer by deacetylation of GlcNAc moieties. Notably, the presence of deacetylated PIA was essential for biofilm formation, immune evasion, adhesion to epithelial cells, and virulence in an animal model of implant infection. 
EXPERIMENTAL PROCEDURES
Bacterial strains and growth conditions-The clinical isolate S. epidermidis 1457 (22) was grown in TSB medium containing 0.5% of filtered glucose, except for overexpression studies with xylose induction, for which basic medium (1% tryptone, 0.5% yeast extract, 0.5% NaCl, 0.1% K 2 HPO 4 ) was used. Cultures were incubated at 37°C with shaking at 140 rpm, unless otherwise noted.
Immuno dot blot assay-To quantify PIA production, corresponding amounts of S. epidermidis cells and culture supernatants were used. Surface-located PIA was extracted by incubating the cells in 0.5 M EDTA pH 8.0 (final volume: 1:50 of cultures) for 5 min at 100°C. Staphylococcal supernatants were concentrated about 50-fold by centrifugal filter devices (Amicon Ultrafree-MC, YM-10). 3-µl aliquots of the samples were spotted on a nitrocellulose membrane, air-dried, and PIA was detected using anti-PIA antiserum as described previously (23) 
Construction of an isogenic icaB deletion mutant, an icaB-complementing vector, and
icaB overexpression vectors-To delete icaB in S. epidermidis 1457, PCR-amplified regions flanking the icaB gene and an erythromycin resistance cassette were cloned into plasmid pBT2 (24) , yielding plasmid pBTΔicaB, which was used for allelic replacement as described (25) . The proper integration of the resistance gene marker ermB was verified by direct sequencing of the genomic DNA at the borders of the PCR-derived regions. S. Human cell culture and adherence assay-A2058 human skin epithelial cells (ATCC CRL-11147) were used to compare the level of adherence of S. epidermidis wild-type and icaB mutant strains as described (26) . Experiments were performed in quadruplicate, and results were expressed for each experiment as the mean number of S. epidermidis cells per A2058 cell ± standard error of the mean.
Isolation of human PMNs and phagocytosis experiments-PMNs were isolated from
heparinized venous blood of healthy individuals with a standard method (27) . All studies were performed in accordance with a protocol approved by the Institutional Review Board for Human Subjects, NIAID. Cell preparations contained >99% PMNs and all reagents used contained <25.0 pg/ml endotoxin. Phagocytosis of S. epidermidis by human PMNs was analyzed by flow cytometry with a previously described method (27) .
Peptide bacterial killing assays-Assays were performed as described previously (5 
RESULTS
IcaB is responsible for PIA deacetylation-In these studies, we investigated the mechanism responsible for the formation of deacetylated GlcNAc in PIA and its role in virulence of S. epidermidis. On the basis of sequence similarity to oligosaccharide deacetylases in other organisms, we hypothesized that icaB is involved in the deacetylation of PIA. To determine the role of icaB, we constructed an isogenic icaB mutant of a biofilm-forming, clinical S. epidermidis isolate by allelic replacement with an erythromycin resistance cassette (Fig. 1) . Correct insertion of the cassette in the chromosome was confirmed by sequencing of the flanking regions. Absence of the icaB transcript in the icaB mutant and maintained expression of icaC, the only gene located downstream of icaB in the ica operon (Fig. 1) , were verified by RT-PCR (data not shown). PIA deacetylation was analyzed with size exclusion chromatography/electrospray mass spectrometry (SEC/ESI-MS). In contrast to previously used protocols (4, 16) , this method does not require extensive purification of PIA prior to analysis, which may lead to precipitation and selective enrichment of specific forms of PIA. PIA from the wild-type strain revealed fragmentation patterns that included ions originating from deacetylated residues (Fig. 2) . These ions were not found in PIA from the icaB mutant strain (Fig. 2) , indicating that this strain is deficient in PIA deacetylation.
In addition, we purified PIA from mutant and wild-type strains and analyzed the degree of deacetylation by a conventional method based on the detection of free amino groups (17) . We found that 16.4% ±9.9% of GlcNAc residues in the wild-type strain were deacetylated, whereas no deacetylation was detected in the icaB mutant strain. These 12 findings indicate that the introduction of deacetylated GlcNAc into PIA occurs by a dedicated mechanism to deacetylate a polymeric PIA precursor. Importantly, our data demonstrate that the IcaB protein is involved in PIA deacetylation. Further, our ESI-MS data provide novel insight into the mechanism of oligosaccharide deacetylases. They indicate that the PIA-deacetylating enzyme modifies GlcNAc residues in PIA in random rather than in a specific distance. This theory is supported by the following observations. First, GlcNAc oligomer peaks in the wild-type strain appeared in series with varied rather than uniform degrees of deacetylation (Fig. 2) . Second, we found fragments of short GlcNAc oligomers that are multiply deacetylated (Fig. 2) . For example, the presence of a peak corresponding to 2 glucosamine residues (323 Da) confirms this idea and indicates that the enzyme is capable of deacetylating adjacent GlcNAc residues.
Deacetylation is crucial for attachment of PIA to the bacterial cell surface-Deacetylation introduces positive charges in the otherwise neutral PIA molecule, as free amino groups are exposed that become protonated at neutral and acid pH. We found that the altered chemistry of deacetylated PIA significantly affected its biophysical properties. We have previously shown that PIA is located in fibrous strands on the S. epidermidis surface (5). In contrast to the wild-type strain, PIA from the icaB mutant was released to the culture filtrate (Figs. 3A, B) . Thus, deacetylation is essential for surface localization of PIA. Moreover, completely acetylated PIA from the icaB mutant strain had a much higher tendency to precipitate in aqueous solution compared with partially deacetylated PIA from the wild-type strain. Hence, deacetylation of PIA is important for solubility in an aqueous environment.
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IcaB is a surface-bound protein-We next determined the subcellular location of the IcaB protein using IcaB-specific antisera (Fig. 3C) . Notably, IcaB was extracted from the wildtype and icaB-overexpressing strains by boiling cells with sodium dodecylsulfate, an established method to isolate proteins that are non-covalently attached to the surface of gram-positive bacteria (18) . IcaB was not detected in the culture filtrate or cellular fractions (from which surface-attached proteins were previously released) of these strains nor in any fraction derived from the icaB mutant strain. IcaB had an apparent molecular weight of ~ 30 kDa, which is in good accordance with the theoretical value of the translational product after cleavage of the putative signal peptide (30.4 kDa). Thus, our data indicate that IcaB is exported and attached to the staphylococcal cell surface by noncovalent interaction. PIA deacetylation therefore very likely occurs in the cell surface matrix.
PIA deacetylation is indispensable for efficient biofilm formation and surface
colonization-To investigate the impact of PIA deacetylation on major virulence mechanisms of S. epidermidis, we first determined colonization of an abiotic surface and human epithelial cells in vitro. Biofilm formation on plastic in vitro was completely abolished in the icaB mutant strain, and restored in the complemented mutant (Fig. 4A) .
Further, adhesion of the icaB mutant to epithelial cells was significantly lower than that of the wild-type (p<0.0001) and complemented mutant strains (p<0.0001) (Fig. 4B) .
These results indicate that PIA deacetylation contributes to efficient colonization of surface matrices relevant to S. epidermidis infection. PIA deacetylation is required for immune evasion-Immune evasion is believed to be a key virulence mechanism of S. epidermidis. This notion is underscored by the fact that virulence of this pathogen is based on prolonged persistence in relative silence rather than on aggressive virulence factors (3). We have recently shown that PIA protects S.
epidermidis from major components of innate host defense (5) . To test if deacetylation of PIA plays a major role in immune evasion processes, we evaluated phagocytosis by human neutrophils and resistance to antibacterial peptides of S. epidermidis icaB mutant and wild-type strains. Phagocytosis by human neutrophils was significantly increased at all time points in the icaB mutant strain (Fig. 5A ). Inasmuch as neutrophils are the critical effector cells in human innate host response to bacterial infections, the data indicate that PIA deacetylation is important for immune evasion. Further, the icaB mutant strain showed significantly higher sensitivity to the effects of LL-37 and human β-defensin 3, 2 representative antibacterial peptides from human skin and neutrophil specific granules (Figs. 5B, C) . These findings indicate that IcaB plays a key role in protecting S.
epidermidis from the microcidal effects of innate host defense components. Remarkably, the values for the icaB mutant were in the same range as those that we have obtained earlier for a mutant of the same strain devoid of PIA (5). Thus, the role of PIA in immune evasion is largely dependent on deacetylation of GlcNAc residues. (Fig. 6) . Similarly to described models of device-related infection with S. epidermidis (7, 19) , the model includes the insertion of a piece of medical tubing under the skin of the dorsum of the animals. After 1 week of infection, bacteria on the implant were counted. Significantly fewer bacteria were detected at the infection site in the mice infected with the icaB mutant compared to those infected with the wild-type (p=0.0142). These results indicate that deacetylation of PIA represents an important virulence mechanism during S. epidermidis device-related infection. In this report, we investigated how enzymatic modification of EPS in S .
An isogenic icaB mutant shows impaired persistence in a model of device-related infection-Persistence
epidermidis influences biofilm formation and virulence. SEC/ESI-MS analysis revealed that PIA in an icaB deletion mutant was completely acetylated. The introduction of deacetylated GlcNAc into PIA therefore occurs by a dedicated mechanism to deacetylate a polymeric PIA precursor rather than by incorporation of UDP-glucosamine as an alternative substrate of the IcaAD UDP-GlcNAc transferase. Given that IcaB also has similarity to oligosaccharide deacetylases, our results strongly suggest that the protein is the PIA-deacetylating enzyme. However, this remains to be demonstrated by conversion of acetylated PIA with purified IcaB. Further, our data indicate that (i) deacetylation sites in wild-type PIA are randomly distributed and (ii) deacetylation by the surface-attached IcaB occurs in the cell surface matrix, in contrast to the other steps in PIA biosynthesis, which take place inside the cell (10) . Based on our results, we propose a model of PIA biosynthesis, which is shown in Figure 7 .
Comparison of the icaB mutant with the wild-type strain allowed investigation of the biological role of deacetylation and the introduction of positive charges in the PIA molecule. The icaB mutant strain had a strong defect in colonization and resistance against innate host defense, which was reflected by significantly decreased virulence in a mouse model of catheter-related infection. Notably, many of the biological effects seen in an icaB mutant strain may be related to the fact that non-deacetylated PIA was not retained on the S. epidermidis cell surface. Deacetylated PIA is cationic due to free amino groups (theoretical pK=6.9) that become protonated at neutral or acidic pH. The cationic character of PIA presumably is essential for the attachment of PIA to the negatively charged bacterial cell surface. By PIA production, the bacteria thus can efficiently change the electrostatic properties of their cell surface. This is very likely responsible for the resistance against antibacterial peptides, which are usually cationic (5) . In comparison to other known EPS components, which are almost all neutral or negatively charged, PIA might therefore be exceptionally well suited for its role in biofilm formation and immune evasion.
In conclusion, we demonstrate that enzymatic modification of PIA by deacetylation is crucial for biofilm formation, immune evasion, and virulence of S.
epidermidis. To our knowledge, this is the first report to show that modification of a specific EPS component by a dedicated mechanism affects virulence and pathogen success in biofilm-associated infection. Since PIA and homologues of the ica gene cluster have been discovered in a variety of pathogenic and biofilm-forming microorganisms, PIA deacetylation likely represents a widespread mechanism of virulence. Furthermore, PIA biosynthesis is a potential target for anti-biofilm drug development (21) . Targeting Deacetylation results in additional peaks with a mass defect of multiples of 42 Da, the mass of an acetyl rest (red arrows). PIA from the complemented icaB mutant strain S.
epidermidis ΔicaB (pRBicaB) produced ESI-MS peaks consistent with normal deacetylation observed in the wild-type strain (not shown). ΔicaB, isogenic icaB mutant strain. 
